Q2 2025 Earnings Call Transcript August 7, 2025 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.15, ...

GERN reported underlying demand growth of 17% for Rytelo in Q2 vs. Q1 and increased use in early lines of therapy. Click here ...

August 6, 2025Perrigo Company plc misses on earnings expectations. Reported EPS is $-0.06078 EPS, expectations were $0.59.

LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 – – Data readouts for CHS-114 and casdozokitug on track for 1H 2026 ...

LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 - - Data readouts for CHS-114 and casdozokitug on track for 1H 2026 - - Q2 2025 ending cash, cash equivalents and marketable ...

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

Parsons, SVP of Commercial, commented, "From launch to the end of Q2, we were up to approximately 4,700 unique cardiology and nephrology prescribers." Parsons attributed the growth to the Q4 2024 ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

Continued Vafseo® (vadadustat) growth with Q2 2025 net product revenues increasing to $13.3 million; Total Q2 2025 net ...

Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.

The jury in Sean “Diddy” Combs’ sex trafficking trial said Tuesday that it has reached a verdict on four of five counts against the hip-hop mogul.

Andrew Peller Limited (TSX: ADW.A / ADW.B) (“APL” or the “Company”) announced today results for the three months ended June 30, 2025.